Skip to content
Independent analysis of NHS open data
PharmaInsight

Abacavir and lamivudine

Infections Antiviral drugs BNF 0503010Z0
Data updated July 2025 Download CSV

Abacavir and lamivudine was dispensed in England in July 2025, with 1 items, down 50.0% on a year earlier.

1items -50%

Dispensed in July 2025

2items

Rolling 12 months

£12

Net ingredient cost · July 2025

Figure 1. Abacavir and lamivudine: national items dispensed by month

0 2 4 Jan 2021 Sep 2021 Mar 2022 May 2023 Feb 2024 Oct 2024 Jul 2025 1 Jan 2021: 3 Feb 2021: 1 Apr 2021: 1 Jun 2021: 2 Jul 2021: 3 Aug 2021: 2 Sep 2021: 1 Oct 2021: 4 Nov 2021: 1 Dec 2021: 1 Jan 2022: 1 Feb 2022: 2 Mar 2022: 1 May 2022: 2 Jul 2022: 1 Aug 2022: 1 Sep 2022: 1 Dec 2022: 1 May 2023: 1 Jun 2023: 1 Jul 2023: 1 Sep 2023: 1 Oct 2023: 1 Jan 2024: 1 Feb 2024: 3 Apr 2024: 1 Jun 2024: 1 Jul 2024: 2 Aug 2024: 1 Sep 2024: 2 Oct 2024: 1 Nov 2024: 2 Dec 2024: 1 Jan 2025: 2 Feb 2025: 2 Mar 2025: 2 Jun 2025: 1 Jul 2025: 1

Source: NHSBSA Prescription Cost Analysis, to July 2025

Download CSV
Embed this chart

At a glance

  • Therapeutic class Antiviral drugs
  • Presentations 1 shown
  • Average cost / item £11.74
  • Year on year Down 50.0% on a year earlier
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, July 2025

The individual products dispensed under Abacavir and lamivudine this month.

Presentations of Abacavir and lamivudine, July 2025
Presentation BNF code Items Net ingredient cost
Abacavir 600mg / Lamivudine 300mg tablets 0503010Z0AAAAAA 1 £12

Source: NHSBSA Prescription Cost Analysis · to July 2025 OGL v3.0

Where Abacavir and lamivudine is dispensed

The regions and dispensing practices with the highest Abacavir and lamivudine volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Abacavir and lamivudine with

Other medicines in the same BNF section, by prescribing volume.